drugset / Trial / NCT07220889
Single Ascending Dose and Multiple Ascending Dose Evaluation of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MDI-2517 in Healthy Participants
RandomizedSequentialQuadruple-blindTreatment
Summary
The goal of this clinical trial is to learn if drug MDI2517 is safe and to learn more about its drug effects in healthy participants. Healthy participants will take single or multiple doses of drug and the safety and drug levels will be measured.
Timeline
- Start
- 2025-11-04
- Primary completion
- 2025-12-16
- Completion
- 2026-01-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | MDI-2517 | Unknown | 800 mg | Oral |
| Comparator | MDI-2517 | Unknown | 1600 mg | Oral |
| Comparator | MDI-2517 | Unknown | 2400 mg | Oral |
| Comparator | MDI-2517 | Unknown | 3600 mg | Oral |
Indications
No indication recorded.